Ezatiostat
SIGMA/SML1081 - ≥98% (HPLC)
Synonym: γ-Glu-S-BzCys-PhGly diethyl ester; (2S)
CAS Number: 168682-53-9
Empirical Formula (Hill Notation): C27H35N3O6S
Molecular Weight: 529.65
Linear Formula: C27H35N3O6S
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C27H35N3O6S/c1-3-35-26 |
InChI key | GWEJFLVSOGNLSS-WPFOTENUSA |
Quality Level | 100 |
solubility | DMSO: 5 mg/mL, clear (warmed) |
storage temp. | 2-8°C |
Application: | Ezatiostat has been used as glutathione S-transferase P1 (GSTP1) inhibitor: • to study its effects on peroxiredoxin 6 (PRDX6) inhibition in neonatal rat testicular gonocytes • for the incubation of bronchial epithelial cells in proteolysis assay • to study its effects on the cystine-glutamate antiporter xCT (SLC7A11) expression in tumor cells |
Biochem/physiol Actions: | Ezatiostat is an inhibitor of glutathione S-transferase P1-1 (GSTP1-1) with hematopoiesis-stimulating activity. After intracellular de-esterification, the active form of ezatiostat binds to and inhibits GST P1-1, leading to activation of Jun kinase (JNK), a key regulator of cellular growth and differentiation of blood precursor cells, thereby restoring JNK and MAPK pathway activities and promoting MAPK-mediated cellular proliferation and differentiation. Ezatiostat promotes the proliferation and maturation of hematopoietic precursor cells, granulocytes, monocytes, erythrocytes and platelets. Ezatiostat has recently been given orphan drug designation for it for the treatment of myelodysplastic syndrome. |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |